Active	Status	Sponsor type	Region	Phase	Filter
5 Active 8 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Evans, David
NCT06178679: Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)	Recruiting	3	175	US	ST-100 (vezocolmitide), Vehicle	ORA, Inc., Stuart Therapeutics, Inc.	Dry Eye Disease	06/24	07/24
NCT05927753: Study to Evaluate the Clinical Performance of Deseyne (Vifilcon C) Daily Disposable Soft Contact Lens	Completed	N/A	81	US	Deseyne Daily Disposable Contact Lens (Test Device)	Bruno Vision Care	Refractive Error - Myopia Bilateral	01/24	01/24
McLaurin, Eugene
NCT04770610 / 2020-003976-42: Study of OT-101 in Treating Myopia	Active, not recruiting	3	678	US	OT-101 Ophthalmic Solution, Investigational Product, Vehicle, Placebo	Ocumension (Hong Kong) Limited, ORA, Inc., Statistics & Data Corporation	Myopia, Progressive	03/27	04/27
NCT06394973: Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients with Open-angle Glaucoma or Ocular Hypertension	Active, not recruiting	2	126	US	T4090 0.2%, T4090 0.3%, Rhopressa®	Laboratoires Thea	Glaucoma, Ocular Hypertension	05/25	05/25
O'Neal, Chassie
NCT04770610 / 2020-003976-42: Study of OT-101 in Treating Myopia	Active, not recruiting	3	678	US	OT-101 Ophthalmic Solution, Investigational Product, Vehicle, Placebo	Ocumension (Hong Kong) Limited, ORA, Inc., Statistics & Data Corporation	Myopia, Progressive	03/27	04/27